Brought to you by:
Spotlight: Vascular surgeons in the news
Daniel Clair, MD, has been named the inaugural chair of the newly formed Department of Vascular Surgery in the Section of Surgical Sciences at Vanderbilt University Medical Center and professor of vascular surgery in the Vanderbilt University School of Medicine,…
UCLA-SVS review course starts Oct. 1
There’s less than a month left to register for the Sixth Annual UCLA-SVS Symposium set to take place Oct. 1 to 3 at the Beverly Hilton in Beverly Hills, California. “A Comprehensive Review and Update of What’s New in Vascular…
Save the date for new PAD skills workshop
September is National PAD Awareness Month, and the Society for Vascular Surgery (SVS) will spend the month not only calling attention to causes and treatment for the disease, but also planning a peripheral arterial disease (PAD) skills workshop. The hands-on…
Endologix launches randomized study of Alto EVAR device
Endologix today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the company’s Alto abdominal stent graft system to other commercially available endovascular aneurysm repair (EVAR) devices for the treatment of abdominal…
What is taxonomy and how does it affect vascular surgeons?
Have you ever had a bill denied for services of your assistants and not known why? Have you received cryptic messages on an explanation of payments that indicates your assistant is not allowed to bill for services? As the use…
SVS: A lesson in unity through diverse talent
Today’s emphasis on diversity is nearly inescapable, while examples of true unity seem scarcer. Is there really a way the two can co-exist or work together beneficially? Consider some of your favorite bands, or even successful sports teams. Even a…
First patient enrolled in BIONETIC-I study of iliac artery treatment
Biotronik has announced the first patient enrollment in the BIONETIC-I study of the safety and efficacy of the Dynetic-35 cobalt chromium balloon-expandable stent system for the treatment of atherosclerotic peripheral arterial disease (PAD) lesions in the iliac arteries. The study…
VAM 2021 structural changes prove hit with attendees
It was an epic return: nearly 700 abstracts presented in six plenaries and several other forums; six concurrent sessions; six SVS breakfast sessions; three postgraduate courses; six “Ask the Experts” presentations; more than 1,000 in-person professional attendees; nearly 400 livestreaming…
EVS 2021: Vascular surgery as ‘an enabling service’ for the wider healthcare system
Vascular surgery is as important as anesthesia in providing a safe operating room (OR), Richard Powell, MD, the vascular section chief at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, told an Eastern Vascular Society (EVS) annual meeting (Sept. 23–26) issues…
‘Proceed cautiously in use of DCBs in CLTI patients with advanced WIfI stage’
The last several years have seen ongoing controversy and debate about the risks and benefits of paclitaxel-coated devices (PCDs) for patients with peripheral arterial disease (PAD). The latest contribution from Konstantinos Katsanos, MD, and colleagues raises questions about potential increased…